Total Payments
$3,702
2024 Payments
$1,190
Companies
42
Transactions
218
Medicare Patients
6,712
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,660 (98.8%)
Travel$29.40 (0.8%)
Education$13.40 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,660 | 215 | 98.8% |
| Travel and Lodging | $29.40 | 2 | 0.8% |
| Education | $13.40 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $428.60 | 24 | $0 (2024) |
| Biogen, Inc. | $393.32 | 21 | $0 (2024) |
| PFIZER INC. | $388.53 | 42 | $0 (2024) |
| ABBVIE INC. | $316.01 | 27 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $241.28 | 13 | $0 (2024) |
| Genentech USA, Inc. | $160.01 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $143.68 | 9 | $0 (2023) |
| Amgen Inc. | $138.84 | 7 | $0 (2024) |
| UCB, Inc. | $122.24 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $116.71 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,190 | 70 | Amneal Pharmaceuticals LLC ($205.60) |
| 2023 | $863.68 | 58 | Lilly USA, LLC ($192.06) |
| 2022 | $589.24 | 40 | ABBVIE INC. ($175.88) |
| 2021 | $129.27 | 6 | Eisai Inc. ($50.00) |
| 2020 | $67.24 | 4 | Biogen, Inc. ($55.85) |
| 2019 | $297.80 | 10 | Genentech USA, Inc. ($92.38) |
| 2018 | $345.66 | 17 | Medtronic Vascular, Inc. ($101.94) |
| 2017 | $219.00 | 13 | Biogen, Inc. ($113.89) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Rare Disease | ||||||
| 10/23/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PAIN | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Neuroscience | ||||||
| 09/06/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Neurology | ||||||
| 08/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROLOGY | ||||||
| 07/31/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $49.96 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,907 | 2,912 | $745,202 | $364,536 |
| 2022 | 9 | 1,536 | 2,638 | $593,066 | $298,029 |
| 2021 | 9 | 1,484 | 2,587 | $499,278 | $288,240 |
| 2020 | 10 | 1,785 | 2,805 | $568,018 | $299,218 |
Total Patients
6,712
Total Services
10,942
Medicare Billing
$1.3M
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 726 | 1,581 | $268,667 | $143,441 | 53.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 263 | 286 | $171,600 | $101,132 | 58.9% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 109 | 109 | $54,500 | $23,548 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 166 | 166 | $41,500 | $19,782 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 128 | 132 | $37,620 | $17,602 | 46.8% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 67 | 71 | $24,850 | $14,908 | 60.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 42 | 42 | $25,200 | $11,848 | 47.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 42 | 42 | $49,350 | $6,523 | 13.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 100 | $10,500 | $6,236 | 59.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 155 | 181 | $22,625 | $6,095 | 26.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 40 | 77 | $15,400 | $6,020 | 39.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 36 | $5,040 | $3,372 | 66.9% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 19 | 19 | $11,400 | $1,520 | 13.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 26 | 26 | $2,080 | $1,157 | 55.6% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 30 | 30 | $3,750 | $728.48 | 19.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 13 | 14 | $1,120 | $623.00 | 55.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 720 | 1,695 | $262,246 | $158,446 | 60.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 134 | 137 | $68,500 | $30,472 | 44.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 93 | 93 | $55,800 | $29,274 | 52.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 130 | 135 | $38,475 | $20,967 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 145 | 146 | $36,500 | $18,610 | 51.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 69 | 131 | $26,200 | $10,880 | 41.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 60 | 61 | $71,675 | $10,601 | 14.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 142 | $14,910 | $8,070 | 54.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 21 | 21 | $12,600 | $7,166 | 56.9% |
About Dr. Bruce Dopler, MD
Dr. Bruce Dopler, MD is a Neurology healthcare provider based in Seaford, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992860027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Dopler, MD has received a total of $3,702 in payments from pharmaceutical and medical device companies, with $1,190 received in 2024. These payments were reported across 218 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,660).
As a Medicare-enrolled provider, Dopler has provided services to 6,712 Medicare beneficiaries, totaling 10,942 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Seaford, DE
- Active Since 12/27/2006
- Last Updated 06/17/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992860027
Products in Payments
- EMGALITY (Drug) $298.98
- NURTEC ODT (Drug) $226.88
- RYTARY (Drug) $215.54
- QULIPTA (Drug) $163.63
- KESIMPTA (Drug) $143.68
- TYSABRI (Biological) $121.09
- VYEPTI (Biological) $111.81
- Reveal LINQ (Device) $101.94
- Austedo XR (Drug) $94.18
- ZEPOSIA (Drug) $93.46
- Artemis (Device) $87.31
- APTIOM (Drug) $82.59
- AMYVID (Drug) $82.00
- Aimovig (Biological) $78.66
- ELIQUIS (Drug) $75.27
- UBRELVY (Drug) $70.00
- Proclaim Family of SCS IPGs (Device) $67.47
- Rystiggo (Drug) $65.05
- LYRICA (Drug) $62.47
- ADUHELM (Biological) $54.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.